ABBV Stock Price Forecast. Should You Buy ABBV?
Stock Details
ABBV 208
Abbvie (ABBV) PT Lowered to $208 at BMO Capital
Evan David Seigerman·Tue Nov 12 2024
BMO Capital
ABBV 228
Abbvie (ABBV) PT Raised to $228 at BMO Capital
Evan David Seigerman·Thu Oct 31 2024
BMO Capital
ABBV 210
AbbVie price target raised to $210 from $195 at BofA
Charlie Yang·Thu Oct 31 2024
Bank of America Securities
ABBV 226
AbbVie price target raised to $226 from $215 at Citi
Geoff Meacham·Thu Oct 31 2024
Citigroup
ABBV 195
Abbvie (ABBV) PT Raised to $195 at BofA Securities
Geoff Meacham·Fri Oct 18 2024
Bank of America Securities
ABBV 203
AbbVie initiated with a Market Perform at Bernstein
Courtney Breen·Thu Oct 17 2024
Bernstein
ABBV 209
Abbvie (ABBV) PT Raised to $209 at Piper Sandler
Christopher Raymond·Fri Aug 23 2024
Raymond James
ABBV 214
AbbVie price target raised to $214 from $180 at BMO Capital
Evan Seigerman·Fri Jul 19 2024
BMO Capital
ABBV 190
Abbvie (ABBV) PT Raised to $190 at Piper Sandler
Christopher Raymond·Tue Jun 18 2024
Raymond James
ABBV 185
HSBC Upgrades Abbvie (ABBV) to Buy
Rajesh Kumar·Wed Jun 05 2024
HSBC
ABBV 175
Deutsche Bank Reiterates Hold Rating on Abbvie (ABBV)
James Shin·Fri May 24 2024
Deutsche Bank
ABBV 200
Cantor Fitzgerald Starts Abbvie (ABBV) at Overweight
Louise Chen·Fri May 17 2024
Cantor Fitzgerald
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow